{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:58:30Z","timestamp":1782889110243,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016691","name":"Guangdong Provincial Pearl River Talents Program","doi-asserted-by":"publisher","award":["2017BT01Y093"],"award-info":[{"award-number":["2017BT01Y093"]}],"id":[{"id":"10.13039\/100016691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673433"],"award-info":[{"award-number":["81673433"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872860"],"award-info":[{"award-number":["81872860"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973318"],"award-info":[{"award-number":["81973318"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["201604020121"],"award-info":[{"award-number":["201604020121"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["201804010227"],"award-info":[{"award-number":["201804010227"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017688","name":"Guangdong Provincial Key Laboratory of Construction Foundation","doi-asserted-by":"publisher","award":["2017B030314030"],"award-info":[{"award-number":["2017B030314030"]}],"id":[{"id":"10.13039\/501100017688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ejphar.2021.174283","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:22:38Z","timestamp":1624519358000},"page":"174283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["PEX5 prevents cardiomyocyte hypertrophy via suppressing the redox-sensitive signaling pathways MAPKs and STAT3"],"prefix":"10.1016","volume":"906","author":[{"given":"Minghui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4236-0034","authenticated-orcid":false,"given":"Zhuoming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174283_bib1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/15548627.2018.1537769","article-title":"MTOR-independent autophagy induced by interrupted endoplasmic reticulum-mitochondrial Ca(2+) communication: a dead end in cancer cells","volume":"15","author":"Ahumada-Castro","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2021.174283_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ng0997-49","article-title":"A mouse model for Zellweger syndrome","volume":"17","author":"Baes","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2021.174283_bib3","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0002-9440(10)62534-5","article-title":"Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse)","volume":"159","author":"Baumgart","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2021.174283_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/siny.2001.0089","article-title":"Peroxisomal disorders","volume":"7","author":"Baumgartner","year":"2002","journal-title":"Semin. Neonatol."},{"key":"10.1016\/j.ejphar.2021.174283_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ddrr.1113","article-title":"Peroxisome biogenesis disorders: biological, clinical and pathophysiological perspectives","volume":"17","author":"Braverman","year":"2013","journal-title":"Dev Disabil Res Rev"},{"key":"10.1016\/j.ejphar.2021.174283_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003426","article-title":"PEX5 and ubiquitin dynamics on mammalian peroxisome membranes","volume":"10","author":"Brown","year":"2014","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejphar.2021.174283_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2018.02.021","article-title":"Disruption of peroxisome function leads to metabolic stress, mTOR inhibition, and lethality in liver cancer cells","volume":"421","author":"Cai","year":"2018","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejphar.2021.174283_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/35065000","article-title":"Mammalian MAP kinase signalling cascades","volume":"410","author":"Chang","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.174283_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s12276-017-0007-8","article-title":"PEX5 regulates autophagy via the mTORC1-TFEB axis during starvation","volume":"50","author":"Eun","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejphar.2021.174283_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00395-007-0658-z","article-title":"Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis","volume":"102","author":"Fischer","year":"2007","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejphar.2021.174283_bib11","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.bbadis.2012.06.004","article-title":"Peroxisome biogenesis disorders: molecular basis for impaired peroxisomal membrane assembly: in metabolic functions and biogenesis of peroxisomes in health and disease","volume":"1822","author":"Fujiki","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2021.174283_bib12","first-page":"88","article-title":"MAPK-activated protein kinases (MKs): novel insights and challenges","volume":"3","author":"Gaestel","year":"2015","journal-title":"Frontiers in cell and developmental biology"},{"key":"10.1016\/j.ejphar.2021.174283_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092164","article-title":"ERK: a key player in the pathophysiology of cardiac hypertrophy","volume":"20","author":"Gallo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2021.174283_bib14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.abb.2014.11.009","article-title":"Downregulation of adipose triglyceride lipase promotes cardiomyocyte hypertrophy by triggering the accumulation of ceramides","volume":"565","author":"Gao","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2021.174283_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10741-010-9170-x","article-title":"STAT3 and cardiac remodeling","volume":"16","author":"Haghikia","year":"2011","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ejphar.2021.174283_bib16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00418-012-0941-4","article-title":"The peroxisome: an update on mysteries","volume":"137","author":"Islinger","year":"2012","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2021.174283_bib17","doi-asserted-by":"crossref","first-page":"25011","DOI":"10.1074\/jbc.M203254200","article-title":"Saccharomyces cerevisiae acyl-CoA oxidase follows a novel, non-PTS1, import pathway into peroxisomes that is dependent on Pex5p","volume":"277","author":"Klein","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.174283_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pharmthera.2012.03.007","article-title":"Estrogen and the cardiovascular system","volume":"135","author":"Knowlton","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2021.174283_bib19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1006\/bbrc.2001.5510","article-title":"Cardiac characteristics of transgenic mice overexpressing Refsum disease gene-associated protein within the heart","volume":"286","author":"Koh","year":"2001","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.ejphar.2021.174283_bib20","doi-asserted-by":"crossref","DOI":"10.3791\/54818","article-title":"A model of cardiac remodeling through constriction of the abdominal aorta in rats","author":"Ku","year":"2016","journal-title":"Jove-J Vis Exp."},{"key":"10.1016\/j.ejphar.2021.174283_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1042\/BC20090159","article-title":"Getting a camel through the eye of a needle: the import of folded proteins by peroxisomes","volume":"102","author":"Lanyon-Hogg","year":"2010","journal-title":"Biol. Cell."},{"key":"10.1016\/j.ejphar.2021.174283_bib22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/bph.14538","article-title":"Sirtuin 1 represses PKC-zeta activity through regulating interplay of acetylation and phosphorylation in cardiac hypertrophy","volume":"176","author":"Li","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174283_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbagrm.2010.07.005","article-title":"Ubiquitin-proteasome system and mitochondria - reciprocity","volume":"1809","author":"Livnat-Levanon","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2021.174283_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1083\/jcb.201010022","article-title":"Peroxisome assembly: matrix and membrane protein biogenesis","volume":"193","author":"Ma","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2021.174283_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/CS20070430","article-title":"MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets","volume":"115","author":"Muslin","year":"2008","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2021.174283_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2021.174283_bib27","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/TP.0000000000001691","article-title":"mTOR inhibition and cardiovascular diseases: cardiac hypertrophy","volume":"102","author":"Paoletti","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.ejphar.2021.174283_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCRESAHA.117.311147","article-title":"New insights into the role of mTOR signaling in the cardiovascular system","volume":"122","author":"Sciarretta","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2021.174283_bib29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrm3700","article-title":"Peroxisomes take shape","volume":"14","author":"Smith","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2021.174283_bib30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis","volume":"35","author":"Sun","year":"2015","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.ejphar.2021.174283_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.HYP.0000254415.31362.a7","article-title":"Role of oxidative stress in cardiac hypertrophy and remodeling","volume":"49","author":"Takimoto","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2021.174283_bib32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0735-1097(00)01123-2","article-title":"Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte","volume":"37","author":"Tanaka","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2021.174283_bib33","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","article-title":"Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets","volume":"89","author":"Tham","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejphar.2021.174283_bib34","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1042\/BST0350865","article-title":"Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid","volume":"35","author":"Wanders","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejphar.2021.174283_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1399-0004.2004.00329.x","article-title":"Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders","volume":"67","author":"Wanders","year":"2005","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ejphar.2021.174283_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.mce.2018.02.020","article-title":"PARP1 interacts with STAT3 and retains active phosphorylated-STAT3 in nucleus during pathological myocardial hypertrophy","volume":"474","author":"Wang","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2021.174283_bib37","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1080\/15384101.2017.1376149","article-title":"Role of PEX5 ubiquitination in maintaining peroxisome dynamics and homeostasis","volume":"16","author":"Wang","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejphar.2021.174283_bib38","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.bbadis.2012.04.006","article-title":"Genetics and molecular basis of human peroxisome biogenesis disorders","volume":"1822","author":"Waterham","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2021.174283_bib39","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bbamcr.2015.11.015","article-title":"Human disorders of peroxisome metabolism and biogenesis","volume":"1863","author":"Waterham","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2021.174283_bib40","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/med.21733","article-title":"Autophagy and cardiac diseases: therapeutic potential of natural products","volume":"41","author":"Wu","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejphar.2021.174283_bib41","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1111\/jcmm.14330","article-title":"The role of post-translational modifications in cardiac hypertrophy","volume":"23","author":"Yan","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2021.174283_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1476-5381.2012.01903.x","article-title":"Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-kappaB-dependent transcriptional activity","volume":"168","author":"Yu","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174283_bib43","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/ncb3230","article-title":"ATM functions at the peroxisome to induce pexophagy in response to ROS","volume":"17","author":"Zhang","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2021.174283_bib44","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/CIRCRESAHA.116.308688","article-title":"Deletion of interleukin-6 attenuates pressure overload-induced left ventricular hypertrophy and dysfunction","volume":"118","author":"Zhao","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2021.174283_bib45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00395-018-0698-6","article-title":"Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target","volume":"113","author":"Zhou","year":"2018","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejphar.2021.174283_bib46","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1021\/pr050456l","article-title":"Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats","volume":"5","author":"Zhou","year":"2006","journal-title":"J. Proteome Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921004362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921004362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:16:28Z","timestamp":1762143388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921004362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":46,"alternative-id":["S0014299921004362"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174283","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PEX5 prevents cardiomyocyte hypertrophy via suppressing the redox-sensitive signaling pathways MAPKs and STAT3","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174283","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"174283"}}